HMX Pro Genetics: Nucleic Acid Therapeutics

INDP 644 Subject & Catalog Number

Description

Even with the thousands of approved small molecule drugs at our disposal, there remains a lack of effective prevention and treatment for many diseases. Fortunately, a new and exciting drug modality has emerged called nucleic acid therapeutics that has the potential to address current unmet needs.

This class of drugs uses nucleic acids and closely related compounds for a variety of applications, including regulating gene expression, stimulating the immune system, editing the genome, or supplying new genetic information, with the goal of treating or preventing disease. Learning about nucleic acid therapeutics is therefore essential for anyone working in healthcare and related sectors.

This advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty and industry leaders about nucleic acid therapeutics and the advances in this field that have the potential to treat, prevent, and even cure genetic diseases.

This is a fully online course. Students registering for this course will be automatically enrolled by HMX and will receive a confirmation email from onlinelearning@hms.harvard.edu three days prior to the HMX course start date. All course-related activities will happen through the HMX online platform. Students who complete the course will receive a Certificate of Completion.  For more information please see the FAQ on the HMX website 

https://learn.hms.harvard.edu/frequently-asked-questions and then click on the HMX ONLINE LEARNING link; register via my.harvard, do not use the “apply now” buttons on the HMX website.